Texas Oncology Texas Oncology - Sammons — Dallas, Texas

Texas Oncology Texas Oncology - Sammons is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology Texas Oncology - Sammons has participated in 4 clinical trials.

Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology Texas Oncology - Sammons?

Texas Oncology Texas Oncology - Sammons has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology Texas Oncology - Sammons conducted?

Texas Oncology Texas Oncology - Sammons has 4 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.

Is Texas Oncology Texas Oncology - Sammons accredited by Crixeo Health?

Texas Oncology Texas Oncology - Sammons has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology Texas Oncology - Sammons?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.